Regulatory product record
BONQAT
Product identity, ingredients and source provenance from the regulatory catalogue. Linked clinical evidence has a separate review status.
Owner information handout
Plain-language medication information to review with the owner. Open the handout to print it or download a PDF.
Product identity
- Brand name
- BONQAT
- DIN
- 02562553
- DPD drug code
- 106543
- Regulatory category
- APPROVED_VET_DRUG
- Market status
- MARKETED
- Route(s)
- ORAL
- Pharmaceutical form(s)
- SOLUTION
- Ingredients
- PREGABALIN (50 MG)
- Species (DPD record)
- CATS
- Company
- ORION CORPORATION (DIN owner)
Source and provenance
- Source dataset
- health_canada_dpd_marketed
- Source snapshot date
- Not available in this source
- Source record key
- 106543
- Archive fingerprint (SHA-256)
- 85cc3ce208af3aa57018c3d14d83f90220c436baef7455384b6d48d9774e1c88
Linked clinical reference
Clinical entries are linked through the active molecule. Check their species, formulation, source and review status separately from this product record.
Clinical evidence
Pending clinical review (PROPOSED)Rule-based (RULE_BASED)— applies to the facts and dose entries in this species selection; individual source records retain their own status.
Indications2
Adjunctive therapy of refractory seizures (3rd-line after phenobarbital/bromides); neuropathic/chronic pain
DogExtra-label (EXTRA_LABEL)1 source record · View provenance
- Dog · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Indications table · Not applicable · Extra-label (EXTRA_LABEL) · Pending clinical review (PROPOSED) · Rule-based
Original excerpt: Adjunctive therapy of refractory seizures (3rd-line after phenobarbital/bromides); neuropathic/chronic pain — Extra-label (human drug)
- Dog · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Indications table · Not applicable · Extra-label (EXTRA_LABEL) · Pending clinical review (PROPOSED) · Rule-based
Seizure adjunct; neuropathic pain (emerging use)
CatExtra-label (EXTRA_LABEL)1 source record · View provenance
- Cat · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Indications table · Not applicable · Extra-label (EXTRA_LABEL) · Pending clinical review (PROPOSED) · Rule-based
Original excerpt: Seizure adjunct; neuropathic pain (emerging use) — Extra-label
- Cat · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Indications table · Not applicable · Extra-label (EXTRA_LABEL) · Pending clinical review (PROPOSED) · Rule-based
Dose regimens2
This calculator performs arithmetic only on the sourced dosing field shown for each result — it does not verify the field's accuracy, does not select which field to use for a patient, and does not replace a veterinarian's order. Not for clinical use. Confirm every result against the primary source before dispensing.
Select a species above to calculate a dose.
Adverse effects203
Sedation, ataxia — Most common — usually transient with titration
Other speciesNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Other species · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Side Effects / Adverse Effects table · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
Weight gain, peripheral edema — Human class effects
Other speciesNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Other species · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Side Effects / Adverse Effects table · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
Withdrawal effects (seizures, insomnia, GI) with abrupt stop — Human rule — taper
Other speciesNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Other species · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Side Effects / Adverse Effects table · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
These are counts of spontaneously reported events, not proven adverse effects, causal relationships, or incidence rates.
Bars compare report counts within each species; they do not show incidence.
More reportsFewer reportsDog
- Death by euthanasia13 reports
- Lethargy (see also Central nervous system depression in Neurological)13 reports
- Seizure NOS9 reports
- Vomiting9 reports
- Lack of efficacy - NOS8 reports
- Limb weakness8 reports
- Ataxia7 reports
- Bone and joint disorder NOS7 reports
- Pain NOS7 reports
- Decreased appetite6 reports
- Not eating6 reports
- Abnormal radiograph finding5 reports
Cat
- Lack of efficacy - NOS34 reports
- Lethargy (see also Central nervous system depression in Neurological)20 reports
- Ataxia18 reports
- Overdose14 reports
- Wobbliness13 reports
- Sedation10 reports
- Intentional misuse9 reports
- Medication error NOS9 reports
- Partial lack of efficacy9 reports
- Vomiting8 reports
- Behavioural disorder NOS6 reports
- Death by euthanasia6 reports
Monitoring1
Seizure frequency/pain response; sedation/ataxia; renal values (dose-defining); weight
Species not recordedNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Species not recorded · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Monitoring Parameters · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
Precautions5
Renal insufficiency — dose adjust (renal-only clearance); heart failure caution (human); don't stop abruptly
Species not recordedNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Species not recorded · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Contraindications & Warnings table · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
Pregabalin = gabapentin's stronger, more predictable sibling: same α2δ target, 3–10× potency, ~90% bioavailability (vs gabapentin's saturable absorption) — at a cost premium.
Species not recordedNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Species not recorded · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Clinical pearl · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
Renal-only clearance with zero hepatic metabolism: the dose follows the kidney (reduce in CKD — common in older cats with chronic pain).
Species not recordedNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Species not recorded · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Clinical pearl · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
In dogs, evidence base is thin but real: 7/9 phenobarbital/bromide-refractory dogs had ~60% seizure reduction (Dewey 2009); titrate 2→4 mg/kg over weeks.
Species not recordedNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Species not recorded · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Clinical pearl · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
Taper rather than stop — abrupt withdrawal can unmask seizures.
Species not recordedNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Species not recorded · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Clinical pearl · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
Interactions2
Other CNS depressants (gabapentinoids, opioids, sedatives) — Additive sedation
Species not recordedNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Species not recorded · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Drug Interactions table · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
No hepatic CYP interactions — Clean polypharmacy profile for seizure patients
Species not recordedNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Species not recorded · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Drug Interactions table · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
Pharmacokinetics5
Mechanism — Binds α2δ subunit of voltage-gated Ca²⁺ channels → ↓ release of substance P, glutamate, NE
Other speciesNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Other species · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Pharmacokinetics table · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
Potency — 3–10× gabapentin
Other speciesNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Other species · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Pharmacokinetics table · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
Half-life — Dog 6.9 h; Cat 10.4 h (single-dose PK)
CatNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Cat · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Pharmacokinetics table · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
Elimination — Almost exclusively renal, unchanged — no hepatic metabolism
Other speciesNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Other species · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Pharmacokinetics table · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
Bioavailability — ~90% (human), food-independent
Other speciesNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Other species · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Pharmacokinetics table · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
Pregnancy / lactation considerations1
Limited data; caution — human signals of developmental toxicity at high doses.
Species not recordedNot applicable (NOT_APPLICABLE)1 source record · View provenance
- Species not recorded · Plumb's Veterinary Drug Handbook, 7th ed., p. 1000–1001 — Pregnancy & Lactation · Not applicable · Not applicable (NOT_APPLICABLE) · Pending clinical review (PROPOSED) · Rule-based
Literature references14
References are linked to this drug. Species applicability is not recorded here, so the species filter does not narrow this list. Imported dates do not retain their original precision; confirm dates in the original citation.
- Case Report: Development of persistent genital arousal disorder due to a possible combination of medications.
Study summary not available in the imported record. Open the original citation to review the study.
- Pregabalin as a neuroprotective alternative to methylprednisolone in peripheral nerve regeneration: an experimental study.
Study summary not available in the imported record. Open the original citation to review the study.
- Pregabalin contributes to increased recovery time from isoflurane anaesthesia for magnetic resonance imaging in horses.
Study summary not available in the imported record. Open the original citation to review the study.
- Voltage-Gated Calcium Channels Play a Central Role in Caenorhabditis elegans Response to Noxious Heat.
Study summary not available in the imported record. Open the original citation to review the study.
- Analgesic efficacy of pregabalin in dogs undergoing mastectomy with ovariohysterectomy.
Study summary not available in the imported record. Open the original citation to review the study.
Sources: PubMed, National Library of Medicine; openFDA, U.S. Food and Drug Administration; Plumb DC. Plumb's Veterinary Drug Handbook. 7th ed. PharmaVet Inc; 2011.